taurocholic acid has been researched along with sulindac in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bolder, U; Cerrè, C; Elferink, RP; Hagey, LR; Hofmann, AF; Schteingart, CD; Ton-Nu, HT; Trang, NV | 1 |
| Brouwer, KL; Lee, JK; Paine, MF | 1 |
| Fricker, G; Kläs, J; Masereeuw, R; Reichel, V | 1 |
5 other study(ies) available for taurocholic acid and sulindac
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bicarbonates; Bile; Bile Canaliculi; Bile Ducts; Biliary Fistula; Biological Transport; Biotransformation; In Vitro Techniques; Kinetics; Liver Circulation; Male; Perfusion; Rats; Rats, Sprague-Dawley; Sulindac; Taurocholic Acid | 1999 |
Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Cells, Cultured; Estradiol; Hepatocytes; Humans; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nitrofurantoin; Organic Anion Transporters; Rats; Sulindac; Taurocholic Acid | 2010 |
Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Choroid Plexus; Cyclic AMP; Estrone; Fluorescent Dyes; Male; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; Neuroprotective Agents; Organic Anion Transporters, Sodium-Independent; Phosphodiesterase Inhibitors; Piperazines; Potassium; Potassium Cyanide; Purines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Sildenafil Citrate; Sodium; Sulfones; Sulindac; Taurocholic Acid | 2010 |